U.S. federal trademark · Serial No. 97577353
Pharmaceutical and therapeutic agents for use in cellular regeneration and cellular rejuvenation; pharmaceutical and therapeutic agents for the treatment of age-related diseases, and the treatment of degenerative diseases; pharmaceutical and therapeutic agents for use in targeting or regulating senescent cells; pharmaceutical and therapeutic agents designed to directly target and regulate senescent cells for cellular regeneration, cellular rejuvenation to restore cell health, treatment of age-related diseases, treatment of degenerative diseases, anti-aging treatments, treatments to reverse human disease, and treatment of human disease; cells for regenerative medicine for the treatment of age-related diseases, treatment of degenerative diseases, anti-aging, to reverse human disease, and to directly target and regulate senescent cells; clinical medical reagents
medical and medical clinical research and development for others in the field of cellular rejuvenation; medical and scientific research, namely, conducting preclinical research and clinical trials
providing health and medical information; providing a website featuring health and medical information
reagents for research purposes for drug discovery and development; Diagnostic reagents for clinical or medical laboratory use
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.